Anti L’Age
FDA issued a warning letter to Anti L'Age (owner Dr. Arash Mohrdar, Riverside, CA) following a September–October 2024 facility inspection, citing extensive CGMP violations for three dietary supplement products — ESR Amino, Transfer Factor C, and Heart Amino — including failure to establish product specifications, maintain batch records, or implement quality control procedures. The products were also found misbranded for missing required labeling elements such as the 'dietary supplement' statement of identity, adverse event reporting contact, manufacturer information, correct serving size declarations, and required FDA structure/function claim disclaimers. FDA warned that failure to adequately address these violations may result in seizure or injunction. The recipient had not responded to the FDA 483 issued at the close of inspection prior to this letter.
Flagged claims (2)
Nutritional Supplement
the labels make structure/function claims but fail to bear the required FDA disclaimer, in accordance with 21 CFR 101.93(b)-(e)
Required actions (2)
Please notify FDA in writing, within 15 working days of receipt of this letter, of the specific steps you have taken to address any violations. Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation.
Failure to adequately address this matter may result in legal action including, without limitation, seizure and injunction.
Does your site contain similar claims?
The free site audit scans your whole site against every entry in this Atlas. Most nutrition / supplements sites match 3-6 patterns.
Run my free site auditWorried about one specific page, ad, or email? Paste it into the free Claim Checker and see what the FDA and FTC would flag, with the precedent next to each one. No email required.
Check specific copy in the Claim Checker